EcoDrugPlus

Ensembl ID : ENSVVUG00000029161
Gene Symbol: -
Cross references: -
45 Possible Orthologues:

Ensembl ID : ENSVVUG00000006666
Gene Symbol: -
Cross references: -
123 Possible Orthologues:

Ensembl ID : ENSVVUG00000009215
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSVVUG00000001939
Gene Symbol: -
Cross references: -
580 Possible Orthologues:

Ensembl ID : ENSVVUG00000000785
Gene Symbol: -
Cross references: -
80 Possible Orthologues:

Ensembl ID : ENSVVUG00000009278
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSVVUG00000000632
Gene Symbol: -
Cross references: -
45 Possible Orthologues:

Ensembl ID : ENSVVUG00000023935
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSVVUG00000009594
Gene Symbol: -
Cross references: -
424 Possible Orthologues:

Ensembl ID : ENSVVUG00000025315
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSVVUG00000029724
Gene Symbol: -
Cross references: -
335 Possible Orthologues:

Ensembl ID : ENSVVUG00000005571
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).